Publication Details

Pubmed26876197
Title: Heterozygous p53(V172F) mutation in cisplatin-resistant human tumor cells promotes MDM4 recruitment and decreases stability and transactivity of p53.
Year: 2016
DOI: https://doi.org/10.1038/onc.2016.12
First Author: Xie
Experimental setup: affinity chromatography technology (Biogrid)
Throughput: Low Throughput (Biogrid)

Interactions

2 interactions
InteractorPartnerSourcesLink
P53_HUMANMDM2_HUMANBioGRIDdetails
P53_HUMANMDM4_HUMANBioGRIDdetails